Kailera Therapeutics Inc is a clinical-stage biotechnology company. Kailera Therapeutics (NAS: KLRA) is based in Waltham, MA and was founded in 2024. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $1.5 billion (Oct 2025). It has raised $1.6 billion.
Last price · $/share
—
Implied valuation
$1.5B
Total raised
$1.6B
Last round
—
Team — not yet on record
No current team members for Kailera Therapeutics (NAS: KLRA) are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kailera Therapeutics (NAS: KLRA) with a free account
·The complete investor list: 14 names
·Watch Kailera Therapeutics (NAS: KLRA): the Monday email on marks, rounds and moves
